Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-24 @ 11:48 PM
NCT ID:
NCT01022151
Eligibility Criteria:
Inclusion Criteria:
1. ASA I-II patients
2. aged 18-55 years
3. scheduled for elective ambulatory surgery
4. duration \>1 h under general anaesthesia
Exclusion Criteria:
1. cardiovascular diseases
2. respiratory diseases
3. neurological diseases
4. psychiatric diseases
5. pregnancy
6. obesity
7. adverse reaction to aminophylline or sevoflurane
8. receiving xanthines, ß-agonist, anticholinergic
9. history of cognitive dysfunction
10. cerebrovascular disease
11. recent history of infection or recent fever
12. adverse reaction to aminophylline or sevoflurane
13. alcoholism
14. drug dependence
15. those receiving xanthines, ß-agonist, anticholinergic, tranquilizers, anticonvulsants or antidepressants
16. those who has habitual coffee consumption exceeding 2 cups per day
17. unable to read
18. suffering from serious hearing or vision impairment
19. those who had not completed primary school
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01022151
Study Brief:
Protocol Section:
NCT01022151